"Once these results are confirmed, PBT2 would become the only compound tested in Alzheimer’s-in-a-Dish to achieve all three of these effects on AD pathology" From the AGM presentation.
Do you understand "the only compound" part.
[Tanzi, a four-time BrightFocus grant recipient, is already using the new method to test 1,200 drugs currently on the market and 5,000 experimental drugs that have made it through the first phase of clinical testing. The next steps are to evaluate dosing and effectiveness, and there is hope that the petri dish approach will narrow the field to only the most promising candidates.
To attempt a screening of this type and at this scale in mouse studies would be nearly impossible, making this an exciting time for Alzheimer’s research."] Thanks Pierre for this link.
http://www.brightfocus.org/alzheimers/article/alzheimers-petri-dish
Is it coming clear to you yet just how good this MPAC platform is. The next step to "evaluate dosing and effectiveness" To me this has great potential. We know from the Lindquist work that the most efficacy was seen just before toxicity. The Whitehead were able to push that boundary because it was just yeast cells. Now Tanzi can do it with PBT2 or any other MPAC on live human AD affected neurons.
- Forums
- ASX - By Stock
- ATH
- PBT2 in postoperative delirium ?????
PBT2 in postoperative delirium ?????, page-25
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ATH (ASX) to my watchlist
|
|||||
Last
0.4¢ |
Change
-0.001(12.5%) |
Mkt cap ! $18.62M |
Open | High | Low | Value | Volume |
0.4¢ | 0.4¢ | 0.4¢ | $7.902K | 2.037M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
40 | 53603756 | 0.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.4¢ | 126995306 | 20 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
39 | 53433756 | 0.003 |
61 | 91668098 | 0.002 |
28 | 124611099 | 0.001 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.004 | 126995306 | 20 |
0.005 | 32272632 | 28 |
0.006 | 15118927 | 23 |
0.007 | 55054408 | 29 |
0.008 | 19128275 | 23 |
Last trade - 14.03pm 15/08/2024 (20 minute delay) ? |
Featured News
ATH (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO & Managing Director
Charles Armstrong
CEO & Managing Director
SPONSORED BY The Market Online